Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted...
3 KB (151 words) - 13:19, 24 October 2023
Clinical Therapeutics Current Drug Delivery Current Drug Metabolism Current Opinion in Pharmacology Current Pharmaceutical Design Current Trends in Biotechnology...
4 KB (383 words) - 22:36, 25 September 2024
of advanced glycation end products in diabetic neuropathy". Current Pharmaceutical Design. 14 (10): 953–61. doi:10.2174/138161208784139774. PMID 18473845...
82 KB (9,416 words) - 06:54, 19 July 2025
Original Paper in 1936 to Recent Advances in GI Ulceration" (PDF). Current Pharmaceutical Design. 23 (27): 4029–4041. doi:10.2174/1381612823666170622110046....
62 KB (6,416 words) - 02:30, 13 July 2025
pentadecapeptide BPC 157: novel therapy in gastrointestinal tract". Current Pharmaceutical Design. 17 (16): 1612–32. doi:10.2174/138161211796196954. PMID 21548867...
9 KB (698 words) - 01:32, 24 May 2025
(2014). "Mitochondrial biogenesis: pharmacological approaches". Current Pharmaceutical Design. 20 (35): 5507–5509. doi:10.2174/138161282035140911142118. hdl:10454/13341...
172 KB (18,911 words) - 08:14, 18 July 2025
Flavin adenine dinucleotide (section Drug design)
flavin cofactors in man: implications in health and disease". Current Pharmaceutical Design. 19 (14): 2649–75. doi:10.2174/1381612811319140014. PMID 23116402...
40 KB (4,323 words) - 22:16, 14 July 2025
Nootropic (redirect from Pharmaceutical cognitive enhancers)
"Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs". Current Pharmaceutical Design...
34 KB (3,368 words) - 06:43, 19 July 2025
Antioxidant (section Pharmaceutical excipients)
"The Antioxidants and Pro-Antioxidants Network: an Overview". Current Pharmaceutical Design. 10 (14): 1677–94. doi:10.2174/1381612043384655. PMID 15134565...
98 KB (10,857 words) - 21:22, 8 July 2025
indoor tanning as a behavioral addiction: a literature review". Current Pharmaceutical Design. 20 (25): 4070–4075. doi:10.2174/13816128113199990615. ISSN 1873-4286...
18 KB (1,965 words) - 22:40, 13 July 2025
of dietary fiber and short-chain fatty acids in the colon". Current Pharmaceutical Design (Review). 9 (4): 347–58. doi:10.2174/1381612033391973. PMID 12570825...
23 KB (2,365 words) - 22:03, 17 July 2025
prediction of protein targets for structure-based drug design". Current Pharmaceutical Design. 19 (12): 2326–2333. doi:10.2174/1381612811319120019. PMID 23082974...
44 KB (5,022 words) - 12:47, 20 April 2025
Enzyme inhibitor (section Discovery and design)
McGuire JJ (2003). "Anticancer antifolates: current status and future directions". Current Pharmaceutical Design. 9 (31): 2593–2613. doi:10.2174/1381612033453712...
104 KB (11,579 words) - 16:29, 17 July 2025
effect of cannabis on perception of time: a critical review". Current Pharmaceutical Design. 18 (32): 4915–22. doi:10.2174/138161212802884852. PMID 22716134...
86 KB (10,132 words) - 14:26, 12 July 2025
"Glucagon and glucagon-like peptide receptors as drug targets". Current Pharmaceutical Design. 12 (14): 1731–50. doi:10.2174/138161206776873671. PMID 16712485...
23 KB (3,140 words) - 04:34, 15 November 2024
"Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents". Current Pharmaceutical Design. 11 (13): 1695–717. doi:10.2174/1381612053764724...
25 KB (2,450 words) - 01:21, 10 May 2025
Parkinson's disease: state of the art and future directions". Current Pharmaceutical Design. 14 (15): 1475–1489. doi:10.2174/138161208784480072. PMID 18537671...
47 KB (5,216 words) - 05:00, 19 July 2025
(2003). "Antibiotic prophylaxis in urologic prosthetic surgery". Current Pharmaceutical Design. 9 (12): 989–96. doi:10.2174/1381612033455198. PMID 12678865...
35 KB (3,760 words) - 12:50, 18 July 2025
"Innate immunity in lophotrochozoans: the annelids" (PDF). Current Pharmaceutical Design. 12 (24): 3043–50. doi:10.2174/138161206777947551. PMID 16918433...
119 KB (13,589 words) - 03:47, 20 July 2025
Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?". Current Pharmaceutical Design. 24 (20): 2264–2282. doi:10.2174/1381612824666180723161811....
34 KB (3,789 words) - 23:22, 17 July 2025
of drugs: efficacy in the treatment of alcoholic patients". Current Pharmaceutical Design. 16 (19): 2103–2112. doi:10.2174/138161210791516404. PMC 3063512...
43 KB (3,758 words) - 18:38, 17 July 2025
horses of conventional lin- stem/progenitor cell isolates". Current Pharmaceutical Design. 17 (34): 3753–71. doi:10.2174/138161211798357881. PMID 22103846...
15 KB (1,583 words) - 03:55, 15 July 2025
peptide in neurodevelopmental disorders: therapeutic potential". Current Pharmaceutical Design. 13 (11): 1079–89. doi:10.2174/138161207780618975. PMID 17430171...
23 KB (2,720 words) - 03:24, 14 June 2025
pharmacokinetic profile, and clinical results in depression". Current Pharmaceutical Design. 11 (12): 1475–93. doi:10.2174/1381612053764805. PMID 15892657...
76 KB (7,456 words) - 13:47, 16 July 2025
Emerging Approach to Targeted Alpha-Particle Radiotherapy". Current Pharmaceutical Design. 6 (14): 1433–1455. doi:10.2174/1381612003399275. PMID 10903402...
82 KB (9,336 words) - 06:00, 21 July 2025
colorectal cancer: the role of vascular endothelial growth factor". Current Pharmaceutical Design. 21 (21): 2960–2967. doi:10.2174/1381612821666150514104244....
153 KB (16,730 words) - 03:36, 19 July 2025
reductase: biochemical characterization and medical significance". Current Pharmaceutical Design. 19 (14): 2574–2593. doi:10.2174/1381612811319140008. PMID 23116396...
36 KB (3,876 words) - 06:31, 19 July 2025
collagen mimetics as angiogenesis promoting superpolymers". Current Pharmaceutical Design. 13 (35): 3608–3621. doi:10.2174/138161207782794176. PMID 18220798...
68 KB (7,452 words) - 06:38, 28 June 2025
disorder—symptom targeted and disorder specific treatment options. Current Pharmaceutical Design, 21(23), 3301–3311. Connor DF, Fletcher KE, Swanson JM (December...
63 KB (5,898 words) - 18:23, 17 July 2025
"Epilepsy, Theories and Treatment Inside Corpus Hippocraticum". Current Pharmaceutical Design. 23 (42): 6369–6372. doi:10.2174/1381612823666171024153144....
38 KB (4,299 words) - 16:09, 25 June 2025